PRINT THIS PAGE US venture capital investment in healthcare rose 23 per cent in 2004 07/01/2005. Source: AltAssets. 
 Health care venture capital investment in the US increased by 23 per cent in 2004 compared with the previous year, according to preliminary figures published by health care financial publisher Irving Levin Associates. More than $6.9bn was channelled into a total of 390 venture capital transactions.
The deal volume increased by just one per cent compared with 2003 but figures show that the value of the two biggest deals was higher than the value of the two largest deals done in 2003. Jazz Pharmaceuticals secured $250m in venture financing and managed care company Ion Health Holdings secured $200m.
In 2004 the most active venture capital firms in the health care markets were Burrill & Company (participated in 18 health care financings), 3i Group, Alta Partners and MPM Capital (each having contributed to 16 venture deals) and Oxford Bioscience (15 venture rounds).
Copyright © 2005 AltAssets
|
